ESPACOMP is a non-profit association established to promote the science of what patients do with medicines they have been prescribed. This science addresses the reasons for medication non-adherence, the clinical and economic consequences of non-adherence, and differences between caregivers’ prescriptions and patients’ execution of those prescriptions. ESPACOMP also promotes the translation of medication adherence research into evidence-based policies, programs and practices that are useful to patients, healthcare providers, healthcare policy makers, and pharmaceutical researchers..
Since 1996, a group of scientists from Belgium and the Netherlands organized the Lowlands Symposium to share their research on patient compliance and persistence with prescribed therapy. This symposium has grown over the years reflecting the increased interest for adherence related issues across Europe. In order to reflect the international expansion of the symposium, in 2006, the organizing committee decided to rename the symposium as the European Symposium on Patient Adherence Compliance and Persistence and to extend it to other European countries. In 2009, The European Society for Patient Adherence, Compliance, and Persistence was founded. The official name of ESPACOMP was changed to International Society for medication adherence in 2019.
Today, the principal activity of ESPACOMP is to organize a yearly symposium. It has become the meeting place for an increasing number of international adherence researchers, pharmacoepidemiologists, statisticians and industry people interested in compliance and persistence.
Honorary Members and Awardees